FDA reviews risks of using adult antipsychotics in children

06/7/2009 | Wall Street Journal, The

Three drugs for adults with bipolar disorder and schizophrenia are effective in children and adolescents but carry side effects, including sedation and weight gain, the FDA said. An advisory panel is scheduled to meet this week to consider the applications of AstraZeneca's Seroquel, Eli Lilly and Co.'s Zyprexa and Pfizer's Geodon for 10- to 17-year-olds.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ